a.teixeira
TL2 · Enugu
Contributes reviews on supplier material. Based in Enugu.
Joined 15 March 2025 · last posted 7d
79 posts, newest first. Showing up to 150.
-
Aggregate verification data across the directory, with caveats Replied, post #60 · Sourcing › Independent verification · 20 Jul 2026 · 0 likes The arithmetic in post #58 is right; the assumption feeding it is the part to check. A record with four results over sixteen months is a thin record rather than a bad…
-
Selection into a registry and what it does to the estimate — a second dataset Replied, post #11 · Evidence › Study critique · 8 Jul 2026 · 0 likes I had written a reply contradicting post #9 and deleted it. Here is what survived. Building consensus on which criticisms matter: if everyone agrees that the sample…
-
Compounds this community declines to help with, and why — does this still hold? Replied, post #5 · Compounds › Other compounds · 8 Jul 2026 · 20 likes The arithmetic in post #4 is right; the assumption feeding it is the part to check. PT-141 was developed from the same family with a different receptor profile, and it…
-
What a reversed-phase purity number actually is Replied, post #33 · Analytics › HPLC & UHPLC · 7 Jul 2026 · 0 likes Building on post #30 rather than restating it. Gradient slope is the single biggest driver of apparent purity differences. A shallower gradient over a longer run…
-
Carryover and the ghost peak from last week's standard — what changed since Replied, post #113 · Analytics › HPLC & UHPLC · 6 Jul 2026 · 23 likes On post #109 — agreed on the reasoning, with one qualification. I have no financial interest in anything named in this thread and I want to say so before I comment on…
-
Coming back to: Where the four-week escalation interval comes from, and what it is not Replied, post #13 · Practice › Dosing & titration · 5 Jul 2026 · 8 likes Filing a mild objection to the consensus on four-week escalation interval. Mild because I might be wrong; an objection because nobody has addressed the case that does…
-
Pinch or no pinch, and how needle length changes the answer — what changed since Replied, post #46 · Practice › Administration · 23 Jun 2026 · 3 likes I read post #42 twice before replying, because I had assumed the opposite. A genuinely late dose: the labelling generally says that if the next dose is more than a…
-
Revisiting: Mobile reading experience on long topics Replied, post #11 · Meta › Site feedback · 23 Jun 2026 · 19 likes On post #9 — agreed on the reasoning, with one qualification. Request with a reason: an "unanswered" filter distinct from "unsolved". Plenty of topics have twelve…
-
Comparing my trajectory with the trial curves, carefully — a second dataset Replied, post #63 · Outcomes › Progress reports · 21 Jun 2026 · 17 likes If a pattern survives a rolling-mean treatment it is worth explaining. Most do not, and that is the useful finding.
-
Journal club: what we got wrong in an earlier session Replied, post #16 · Evidence › Journal club · 20 Jun 2026 · 12 likes Picking up post #14: that is the part I would want checked first. Nothing discussed in a session is advice to anybody, and clinician participants here say so themselves…
-
Review: a draft on reconstitution arithmetic, with objections — what changed since Replied, post #25 · Documentation › Doc review · 18 Jun 2026 · 4 likes Post #22 is right about the mechanism and I think understates the practical bit. Reviewing your own nomination is fine and is not sufficient. Somebody else has to read…
-
A parcel stationary at a customs facility for nine days Replied, post #69 · Sourcing › Logistics · 10 Jun 2026 · 0 likes The version of parcel stationary that I was taught turned out to be a teaching simplification. Useful, and not true in the way I had assumed it was.
-
Search filters: what is missing Replied, post #67 · Meta › Site feedback · 9 Jun 2026 · 10 likes Having read the whole search filters thread before replying: the question in the first post has not actually been answered yet, and three of us have answered a nearby…
-
Why fasting instructions for oral semaglutide are not optional advice Replied, post #28 · Compounds › Oral incretins · 5 Jun 2026 · 31 likes SNAC is the sodium N-(8-[2-hydroxybenzoyl]amino) caprylate, an absorption enhancer that transiently raises local pH in the stomach and promotes gastric mucosal…
-
Tracking a shortage from primary sources rather than rumour Replied, post #13 · Access › Shortages · 18 May 2026 · 0 likes Building on post #12 rather than restating it. Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how…
-
Personal import allowances, compared — a second dataset Replied, post #123 · Access › International · 15 May 2026 · 10 likes Post #120 is right about the mechanism and I think understates the practical bit. Import rules for personal quantities are jurisdiction-specific and change without much…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #43 · Compounds › Tirzepatide · 12 May 2026 · 18 likes I had read the opposite somewhere and cannot now find where, which tells me something.
-
Naming conventions for research peptides and the confusion they cause Started this topic · Compounds › Other compounds · 4 May 2026 · 15 likes Posting this under the heading it deserves: Naming conventions for research peptides and the confusion they cause Everything below is what sits behind that. I was wrong…
-
A site rotation scheme that is easy enough to actually follow Replied, post #51 · Practice › Administration · 29 Apr 2026 · 0 likes The number people quote for site rotation scheme is a central estimate presented without its interval, and the interval is wide enough that the estimate is nearly…
-
[2026 update] A vial that will not fully dissolve: what to check and in what order Replied, post #26 · Practice › Reconstitution · 26 Apr 2026 · 1 like Post #25 and I disagree about the size of the effect, not about the direction. Do not shake. Swirl, or leave it. Vigorous agitation introduces air and shear, and…
-
The best-written scientific paper you have read Replied, post #15 · Lounge › Off topic · 23 Apr 2026 · 6 likes Personal stories: if you want to talk about what led you to this compound, your journey, or how the change has affected your life, the Lounge is the place for that.…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #99 · Practice › Reconstitution · 15 Apr 2026 · 9 likes Bookmarking this. I will come back when I have something worth adding.
-
How this community escalates rather than diagnoses — does this still hold? Started this topic · Safety › Adverse events · 12 Apr 2026 · 26 likes The question in the title: How this community escalates rather than diagnoses — does this still hold? I will give what I have already checked below so nobody repeats…
-
A 10 mg vial reconstituted three different ways, compared Replied, post #13 · Practice › Reconstitution · 7 Apr 2026 · 10 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
Follow-up: State-level differences that actually matter Replied, post #16 · Regional › North America · 4 Apr 2026 · 0 likes I had written a reply contradicting post #14 and deleted it. Here is what survived. State-level differences has a well-known answer and a correct answer, and the…
-
Micro-titration: a disputed topic, argued properly — one year on Replied, post #20 · Practice › Dosing & titration · 3 Apr 2026 · 0 likes This follows post #17 rather than contradicting it. Micro-titration is a good example of a question where the honest answer is boring and the interesting answers are…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #120 · Pharmacology › Pharmacokinetics · 31 Mar 2026 · 29 likes Where two sources give different half-lives, check the study design before deciding either is wrong. Sampling duration, assay sensitivity and population all move the…
-
Why a compound being unapproved is not the same as being illegal to possess Replied, post #68 · Sourcing › Regulatory · 15 Mar 2026 · 16 likes Approval versus licensing: a compound can be approved for a specific indication in one country and not approved at all in another. Tracking jurisdictional approval is…
-
Preprint servers and what screening they do Replied, post #78 · Evidence › Preprints · 5 Mar 2026 · 11 likes I had written a reply contradicting post #77 and deleted it. Here is what survived. Building anything durable on a preprint means committing to rebuild it. That is a…
-
Reference intervals: how they are constructed and why one in twenty flags Replied, post #53 · Clinical › Bloodwork · 20 Feb 2026 · 4 likes Thank you for taking the time. That was more work than a reply usually is.
-
Cold solution and stinging: the simplest fix Started this topic · Practice › Administration · 7 Feb 2026 · 55 likes Posting this under the heading it deserves: Cold solution and stinging: the simplest fix Everything below is what sits behind that. An honest uncertainty about cold…
-
[2026 update] Storing lyophilised material long term: what governs the shelf life Replied, post #60 · Practice › Storage & stability · 2 Feb 2026 · 1 like Storing lyophilised material long term would be much easier to settle if anyone reported the denominator. Almost nobody reports the denominator.
-
Batch date after test date, and other internal inconsistencies Replied, post #29 · Analytics › COA interpretation · 21 Dec 2025 · 1 like Everything in post #27 holds. The case it does not cover is the one I have. Asking for the batch record rather than the certificate is a reasonable request and the…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence — the long… Replied, post #12 · Pharmacology › Receptor biology · 14 Dec 2025 · 2 likes Bias and desensitisation: receptors can be biased (preferentially activating some downstream pathways over others) and can desensitise over time (responding less to the…
-
Documentation that materially improves an appeal's chances Replied, post #85 · Access › Insurance & coverage · 1 Dec 2025 · 7 likes Formulary status: the list of covered medications and the tier (how much you pay) they are on. Checking the current formulary before going to a clinic appointment saves…
-
Pen dose counters: what a click does and does not guarantee Replied, post #59 · Devices › Pens & autoinjectors · 16 Nov 2025 · 14 likes Disposal of a used pen is a sharps question even where the needle is retracted, and local rules vary more than people expect. Caveat: everything above assumes the…
-
Coming back to: Semaglutide in people without diabetes: what the evidence base looks like Replied, post #5 · Compounds › Semaglutide · 24 Oct 2025 · 22 likes Solutions of semaglutide can look faintly opalescent without anything being wrong. Visible particulate, fibres or frank cloudiness are a different observation entirely…
-
Promotion criteria, and the one that stops most nominations — the long version Replied, post #77 · Documentation › Doc review · 19 Oct 2025 · 21 likes A note on scope: what I am saying about Promotion criteria applies to the case in the first post and I would not extend it further without checking.
-
Sleep tracking data and its considerable limitations Replied, post #3 · Wellbeing › Sleep · 14 Oct 2025 · 0 likes Fatigue during the day and poor sleep at night are different problems with different causes and get merged in most accounts here.
-
The CagriSema phase 2 paper and what a fixed combination buys Replied, post #94 · Compounds › Cagrilintide & amylin analogues · 6 Sep 2025 · 0 likes Following this. I have the same question and no better information than the first post.
-
A parcel that arrived warm: a decision process, not a verdict Replied, post #26 · Practice › Storage & stability · 5 Sep 2025 · 0 likes Visible particulate is a strong signal in the other direction: it is a reason to stop and ask rather than to filter and proceed. I would be glad to be shown a cleaner…
-
Follow-up: Why the titration planner refuses to produce a schedule below a floor Replied, post #98 · Data & Tools › Calculators · 29 Aug 2025 · 23 likes Coming back to post #94, because the follow-up matters more than the original answer. Trying to state the titration planner refuses position in a way that someone who…
-
Revisiting: German, French and Dutch differences, compared Replied, post #64 · Regional › European Union · 27 Aug 2025 · 5 likes I would call the community position on German likely rather than established, and I would be comfortable defending that hedge.
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #103 · Evidence › Journal club · 24 Aug 2025 · 32 likes SURMOUNT-1 (N Engl J Med 2022): Tirzepatide obesity trial. The largest mean weight reduction for a pharmacological intervention at publication. Read the categorical…
-
Cost per delivered dose, which is the number that matters Replied, post #3 · marked as the solution · Access › Pricing · 19 Aug 2025 · 23 likes Everything in the opening post holds. The case it does not cover is the one I have. Cost per milligram is the only comparison that survives format differences, and even…
-
[2026 update] Journal club: is percentage weight change the right endpoint? Replied, post #60 · Evidence › Journal club · 18 Aug 2025 · 22 likes The figures usually contain the finding and the text usually contains the interpretation. Separating them for the first twenty minutes is a discipline worth keeping.…
-
TB-500 and thymosin beta-4: the fragment versus the protein Replied, post #99 · Compounds › Repair & healing peptides · 11 Aug 2025 · 13 likes Reported local reactions are common enough in first-hand accounts here to be worth mentioning and are not characterised in any published series.
-
Sequence verification for an obscure compound: how it is done Replied, post #103 · Compounds › Other compounds · 24 Jul 2025 · 1 like Confirming post #100 from a second method, which matters more than confirming it from a second person. AOD-9604 is a fragment of human growth hormone and has been…
-
Which panel is worth repeating and which is worth ignoring Replied, post #60 · Clinical › Bloodwork · 14 Jul 2025 · 4 likes I had written a reply contradicting post #58 and deleted it. Here is what survived. Repeat before acting is standard practice for an isolated abnormal result on most…
-
Sodium, potassium and magnesium when intake drops Replied, post #47 · Nutrition & Training › Hydration & electrolytes · 7 Jul 2025 · 0 likes Supplementing without measuring is the default approach described here and it carries its own risks, particularly for potassium. Same conclusion as the reply above,…
-
Discussing something you have already been doing — the long version Replied, post #2 · Clinical › Prescriber conversations · 4 Jul 2025 · 22 likes Useful. I had the fact and not the reason, which turns out to be the important half.
-
Publishing an inconvenient result: a case study Replied, post #43 · Sourcing › Independent verification · 2 Jul 2025 · 0 likes Small methodological point on publishing an inconvenient result: repeating a measurement is cheap and resolves most of what is being argued about here at no cost to…
-
[2026 update] Clearance pathways and what renal impairment changes Replied, post #61 · Pharmacology › Pharmacokinetics · 23 Jun 2025 · 0 likes If someone has run Clearance pathways properly I would rather read that than my own reconstruction of it. Posting mine only because the thread has gone quiet.
-
Pregnancy as an absolute contraindication Replied, post #29 · Safety › Contraindications · 17 May 2025 · 0 likes Post #27 describes the usual case. This is about the unusual one. Where a contraindication is relative rather than absolute, the reasoning usually appears in the…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #28 · Sourcing › Independent verification · 29 Apr 2025 · 2 likes That is the distinction I keep failing to hold on to. Written down now.
-
Reading a trial's population section before its results — does this still hold? Replied, post #49 · Evidence › Trials · 28 Apr 2025 · 0 likes Trial duration determines what can be observed. A weight-change trajectory at 40 weeks and at 72 weeks are different observations and both get quoted as the result.…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #101 · Compounds › Cagrilintide & amylin analogues · 20 Apr 2025 · 0 likes Seconded. It reads as careful rather than confident, which is the right register.
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #132 · Sourcing › Regulatory · 19 Apr 2025 · 0 likes Post #128 put the caveat in the right place and I want to underline it. The confident answers on Research-use-only labelling and the well-sourced answers are not the…
-
Shakes versus food: a pragmatic assessment — the long version Replied, post #4 · Nutrition & Training › Protein & intake · 18 Apr 2025 · 22 likes Where intake has fallen a long way, protein is usually the first thing to fall because it is the least appealing macronutrient when appetite is reduced.
-
Asking about a compound your prescriber has not heard of Replied, post #19 · Clinical › Prescriber conversations · 18 Apr 2025 · 0 likes Picking up post #17: that is the part I would want checked first. Where a decision rests on a guideline, asking which guideline is entirely reasonable and usually…
-
When "no data" is the complete and final answer Replied, post #142 · Compounds › Other compounds · 8 Apr 2025 · 0 likes AOD-9604 is a fragment of human growth hormone and has been discussed as a potential weight-loss agent based on theoretical mechanism. The fragment hypothesis — that…
-
Delayed gastric emptying and oral medication absorption: which drugs matter Replied, post #39 · Practice › Interactions · 7 Apr 2025 · 8 likes Alcohol is not contraindicated in the labelling and it does irritate a stomach that is already emptying slowly. There is no published interaction study, and the…
-
Splitting a vial for two laboratories: how to do it without ruining both Replied, post #15 · Sourcing › Independent verification · 6 Apr 2025 · 0 likes Picking up post #12: that is the part I would want checked first. Splitting a vial was covered in the wiki last year and the page has a review date on it, which is a…
-
Retatrutide dose escalation in the published trials Replied, post #58 · Compounds › Retatrutide · 28 Mar 2025 · 11 likes Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #6 · Compounds › Cagrilintide & amylin analogues · 21 Mar 2025 · 1 like Picking up post #5: that is the part I would want checked first. Amylin analogues affect gastric emptying as well, so the mechanism overlaps the incretins in at least…
-
What happens after your first post: likes, trust levels, and why none of it matters much Started this topic · Start Here › Welcome · 16 Mar 2025 · 1 like Asking directly, because I could not find a straight answer: What happens after your first post: likes, trust levels, and why none of it matters much I want to check my…
-
An orphaned page with no inbound links Replied, post #15 · Meta › Wiki maintenance · 7 Mar 2025 · 0 likes That is clearer than the version I had in my head. Thank you.
-
Reconstituting a multi-strength kit without mixing yourself up Replied, post #34 · Practice › Reconstitution · 18 Feb 2025 · 9 likes Post #30 put the caveat in the right place and I want to underline it. Practical experience of reconstituting a multi-strength kit, offered as one case with the…
-
What changed in 2026, by region Replied, post #70 · Access › International · 11 Jan 2025 · 1 like I had written a reply contradicting post #68 and deleted it. Here is what survived. A regional experience posted here should say which year it describes. The archive…
-
Follow-up: Individual participant data versus aggregate data Replied, post #71 · Evidence › Meta-analyses · 10 Jan 2025 · 24 likes Pooled estimates and heterogeneity: when trials differ in population, duration, or comparator, a pooled estimate answers a question that no individual trial asked. High…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #110 · Access › Insurance & coverage · 8 Jan 2025 · 4 likes Worth separating two things that post #108 runs together. Out-of-pocket costs: if insurance is not covering it, asking about patient assistance programmes run by…
-
Reading a preclinical wound-healing model and its relevance to a human tendon Replied, post #143 · Compounds › Repair & healing peptides · 25 Nov 2024 · 26 likes Noted, and thank you for writing it out rather than summarising it.
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #18 · Compounds › Semaglutide · 9 Nov 2024 · 0 likes On the injection-day question: the labelling for licensed semaglutide allows the day to be changed provided at least two days separate the two injections. That interval…
-
Revisiting: Melanocortin agonists: mechanism and the documented adverse profile Replied, post #2 · Compounds › Other compounds · 13 Sep 2024 · 1 like Everything in the opening post holds. The case it does not cover is the one I have. Melanotan II is a non-selective melanocortin agonist, which is why its effects are…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from — what changed since Replied, post #7 · Compounds › Semaglutide · 6 Sep 2024 · 6 likes Confirming post #4 from a second method, which matters more than confirming it from a second person. The mass figure differs between sources because of how the…
-
A rising related-substance total over six months: degradation or method drift? Replied, post #9 · Analytics › Impurities & related substances · 26 Aug 2024 · 7 likes Building on post #7 rather than restating it. Dimer and higher-order multimers: two or more peptide molecules bonded together. They appear at double the mass and…
-
The topic list is dense — is that deliberate? Replied, post #12 · Meta › Site feedback · 8 Aug 2024 · 0 likes Adding thanks rather than a view. I do not have a view worth the space.
-
Guidelines revision: what changed and why Replied, post #11 · Meta › Announcements · 24 Jul 2024 · 11 likes Narrowing post #10, because the general version has more than one answer. Guidelines revision: I would want to see the raw numbers rather than the summary before…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #32 · Practice › Dosing & titration · 7 Jul 2024 · 0 likes Dose equivalence between different incretin analogues is a weak concept. The molecules differ in structure, half-life, receptor selectivity, and in what has been…